Previous 10 | Next 10 |
Noteworthy events during the week of January 19 - 25 for healthcare investors. More news on: Epizyme, Inc., Nevro Corp., Generex Biotechnology Corporation, Healthcare stocks news, , Read more ...
Gainers: Neon Therapeutics (NASDAQ: NTGN ) +44% . More news on: Neon Therapeutics, Inc., NantKwest, Inc., Signet Jewelers Limited, Stocks on the move, , Read more ...
HOUSTON, Jan. 16, 2020 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that an abstract on new Phase 1 translational results for BPX-601, its lead GoCAR-T product candidate, ha...
These Penny Stocks Broke Out After Big News If there’s one thing about penny stocks , it’s that they’re very volatile. It’s almost a daily occurrence where we see these cheap stocks make explosive runs. Sometimes there may not even be an actual catalyst behind the ...
Gainers: Sorrento Therapeutics (NASDAQ: SRNE ) +38% . More news on: Sorrento Therapeutics, Inc., Ultragenyx Pharmaceutical Inc., Venus Concept Inc., Stocks on the move, Read more ...
Are These Penny Stocks To Buy Or Should You Avoid Them At All Costs? When it comes to penny stocks to buy , one of the most important things to keep in mind is that it is possible to make a lot of money in short timeframes. Therefore, there is a lot of interest in these cheap stocks. Investor...
Bellicum Pharmaceuticals ( BLCM ) has made some progress in their pipeline, company finances, and corporate agreements. Investors are still waiting for the company to close a partnership for Rivo-cel and the company's Houston manufacturing facility. However, management was able to close a lice...
3 Penny Stocks Just Hit Fresh December Highs, Can They Head Higher? Investing in penny stocks can often be the most rewarding thing for traders and investors alike. The simple reason behind it is the fact that these cheap stocks can often generate enormous returns, quickly. Since penny stoc...
Nano cap Bellicum Pharmaceuticals ( BLCM +14.6% ) is up on 60% higher volume on the heels of its out-licensing deal with MD Anderson Cancer Center for its CaspaCIDe safety switch technology. More news on: Bellicum Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move...
HOUSTON, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that The University of Texas MD Anderson Cancer Center exercised its option to license Bellicumȁ...
News, Short Squeeze, Breakout and More Instantly...
Bellicum Pharmaceuticals Inc. Company Name:
BLCM Stock Symbol:
NASDAQ Market:
Bellicum Pharmaceuticals Inc. Website:
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...
First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...
Kajima Corporation ADR (KAJMY) is expected to report for quarter end 2023-12-31 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 BrewBilt MFG Inc (BBRW) is expected to report for Q4 2023 Correlate Energy Corp. (CIPI) is expected to report for Q4 2023 Hyzon Motors Inc. (...